首页>投融资
Averto Medical
A轮
Averto Medical, Inc.（前身为 Savage Medical, Inc.）是一家处于临床阶段的医疗器械公司，致力于改变胃肠道护理。该公司的首款产品 ColoSeal™ 腔内结肠转流系统可用于结肠直肠癌切除术等手术，而无需创建侵入性临时转流造口。
基本信息
-
公司全称Averto Medical Inc
-
类型胃肠道护理医疗器械开发商
-
产业领域医疗器械、治疗设备
-
公司人数15人以下
-
地址871 Corporate Way Fremont
-
联系电话
-
邮箱
-
成立时间2016-01-01
投融资
-
2024-05-07A轮3050万美元鱼鹰资管CVFLifeSci Venture PartnersVenrock Capital
-
2023-11-29未透露300万美元AlwaysraiseVCLife Science AngelsSynergy
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司，该公司开发了一种先进的放疗平台，能够对不可切除的实体瘤和手术切缘进行局部靶向治疗，称为YntraDose。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息